CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pelthos Therapeutics Inc.
Sign in to watch- Ticker
- PTHS
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 863335449
- Phone
- 919-908-2422
- Business address
- 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
- Former names
- Channel Therapeutics Corp, Chromocell Therapeutics Corp
- 8-K12G3 Other 8-K12G3
- 8-K Event Material agreement · New debt or obligation · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Shareholder vote results · Other events
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Director bought 10,400 shares at $0.94 ($9,825)
- 4 Open-market buy CEO, Pres., CFO, Treas & Secty bought 5,200 shares at $0.97 ($5,044)
- 4 Open-market buy CEO, Pres., CFO, Treas & Secty bought 12,000 shares at an average $0.91 ($10,955)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
Page 8 of 13 · 260 filings